Loading clinical trials...
Loading clinical trials...
Intralymphatic Immunotherapy in Increasing Doses up to 10 000 SQ-U - a Human Randomized Clinical Trial. Substudy.
Conditions
Interventions
ALK Diluent
ALK Alutard SQ 5-grasses or ALK Alutard Birch
Locations
2
Sweden
Allergic Unit at the Department of Oto-Rhino-Laryngology at Skåne University Hospital Lund
Lund, Sweden
ENT-department, Karolinska University Hospital Huddinge (ENT-department B51)
Stockholm, Sweden
Start Date
May 1, 2016
Primary Completion Date
June 20, 2022
Completion Date
June 20, 2022
Last Updated
June 24, 2022
NCT07155499
NCT00092885
NCT00127647
NCT00406783
NCT00135629
NCT04622917
Lead Sponsor
Karolinska Institutet
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions